Marek Drozdz | Director of Research,

Marek Drozdz, Director of Research,, Renbio

Marek Drozdz, PhD, has over 15 years of experience investigating cellular processes in both physiological and disease states. At RenBio he leads research efforts for the clinical advancement of MYO Technology™. Marek received a Ph.D. in Pathology from University of Oxford, and completed a postdoctoral training at Weill Cornell Medical College. 


Day 2 - November 29 @ 12:50

Applications of the MYO technology platform for DNA-Based antibody delivery

last published: 02/Jan/24 12:15 GMT

back to speakers